As of January 22, 2025, Pieris Pharmaceuticals (PIRS) has a market cap of $17.955 million USD. According to our data, Pieris Pharmaceuticals is ranked No.8650 in global market value.
Year | Market Cap | %Change |
---|---|---|
Dec 13, 2024 | $17.96 M |
-6.59%
|
Dec 29, 2023 | $19.22 M |
-82.50%
|
Dec 30, 2022 | $0.11 B |
-72.49%
|
Dec 31, 2021 | $0.40 B |
51.20%
|
Dec 31, 2020 | $0.26 B |
-30.94%
|
Dec 31, 2019 | $0.38 B |
36.09%
|
Dec 31, 2018 | $0.28 B |
-64.77%
|
Dec 29, 2017 | $0.80 B |
437.29%
|
Dec 30, 2016 | $0.15 B |
-38.64%
|
Dec 31, 2015 | $0.24 B |
-11.92%
|
Dec 31, 2014 | $0.27 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Amgen
AMGN
|
$146.98 B |
0.004 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Biogen
BIIB
|
$20.80 B |
0.000 M
|
USA
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Vertex Pharmaceuticals
VRTX
|
$110.22 B |
0.001 M
|
USA
|
Moderna
MRNA
|
$14.82 B |
-0.000 M
|
USA
|
BioMarin Pharmaceutical
BMRN
|
$11.82 B |
0.000 M
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Alnylam Pharmaceuticals
ALNY
|
$34.38 B |
-0.000 M
|
USA
|
Sarepta Therapeutics
SRPT
|
$11.09 B |
0.000 M
|
USA
|
Ionis Pharmaceuticals
IONS
|
$5.13 B |
-0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
Market Cap | = | PIRS Stock Price | * | PIRS Shares Outstanding |
= | $13.60 | * | 1.32 M | |
= | $17.96 M |